Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Offenbach Am Main – page 4

53 clinical trials in Offenbach Am Main, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Offenbach Am Main at a glance
53
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

53 trials in Offenbach Am Main

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lavender Oil
  • Sponsor:Dr. Willmar Schwabe GmbH & Co. KG
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Evommune Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cx-037231
  • Sponsor:Moderna Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Heidelberg University

Breast cancer

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Afatinib
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Offenbach Am Main

What the registry says about research in the country

01 Oncology Research

Extensive research focusing on non-small cell lung cancer treatments, exploring innovative therapies including immunotherapy combinations and targeted treatments for specific mutations.

  • Advanced NSCLC Studies
  • Triple-Negative Breast Cancer
  • Ovarian Cancer Treatments

Multiple trials evaluating novel drug combinations and personalized treatment approaches for various cancer types.

02 Breast Cancer Innovation

Groundbreaking research in breast cancer treatment, particularly focusing on hormone receptor-positive and HER2-negative subtypes.

  • Neoadjuvant Therapies
  • Targeted Treatments
  • Immunotherapy Approaches

Studies exploring combination therapies and personalized treatment strategies for different breast cancer subtypes.

03 Chronic Disease Management

Innovative research addressing chronic conditions including diabetic peripheral neuropathy and pulmonary diseases.

  • Pain Management
  • COPD Treatments
  • Cardiovascular Health

Clinical trials evaluating new therapeutic approaches for improving patient outcomes in chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.